InsidersTradesSigma
에스디생명공학 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 에스디생명공학 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 에스디생명공학 has logged 1 reports. Market capitalisation: €52.6bn. The latest transaction was filed on 24 March 2026 (Sale). Among the most active insiders: 수성자산운용. Every trade is free.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
1 ops.
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,338 of 28,016 companies
25.0
score / 100
Value15
Quality35
FCF yld-9.9%
Earn yld-14%
EV/EBITDA·
ROE·
Gross mgn45%
Net mgn-24%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 24 March 2026
About 에스디생명공학
Listed on the XKRX market, 에스디생명공학 is a company in the healthcare and pharmaceutical sector. It focuses on developing innovative biopharmaceutical solutions.